Millennium Management’s Ascendis Pharma A/S ASND Stock Holding History

Millennium Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,000	Closed	-$3.98M	–	5994
2025 Q3	$3.98M	Buy	+20,000	New	+$3.73M	﹤0.01%	3368
2025 Q2	–	Sell	-10,000	Closed	-$1.56M	–	5839
2025 Q1	$1.56M	Buy	+10,000	New	+$1.43M	﹤0.01%	4007
2024 Q4	–	Sell	-38,000	Closed	-$5.67M	–	5941
2024 Q3	$5.67M	Buy	+38,000	New	+$5.13M	﹤0.01%	2723

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management's ASND Position: Q1 2026 in Review

Millennium Management reduced its Ascendis Pharma A/S (ASND) stake by 28% in Q1 2026, selling an estimated $16.4M and leaving 189,027 shares worth $43.2M. The position accounts for 0.02% of the portfolio, ranked #933.

Millennium Management first reported a position in ASND in Q1 2015 and has held it in 39 quarters since. The position peaked at $162M in Q1 2019. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Millennium Management held 189,027 shares of Ascendis Pharma A/S worth $43.2M as of Q1 2026.
Millennium Management sold 73,302 Ascendis Pharma A/S shares in Q1 2026, an estimated $16.4M.
Ascendis Pharma A/S made up 0.02% of Millennium Management's portfolio in Q1 2026, its #933 holding.
Millennium Management first reported a position in Ascendis Pharma A/S in Q1 2015 and has held it in 39 quarters since.
Millennium Management's Ascendis Pharma A/S position peaked at $162M in Q1 2019.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.